These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30595136)

  • 21. Protocol for a systematic review of methods and cost-effectiveness findings of economic evaluations of obesity prevention and/or treatment interventions in children and adolescents.
    Zanganeh M; Adab P; Li B; Frew E
    Syst Rev; 2018 Apr; 7(1):54. PubMed ID: 29609652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluations of cholesterol-lowering drugs: a critical and systematic review.
    Gumbs PD; Verschuren MW; Mantel-Teeuwisse AK; de Wit AG; de Boer A; Klungel OH
    Pharmacoeconomics; 2007; 25(3):187-99. PubMed ID: 17335305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing Alzheimer's disease: a systematic review of economic evaluations.
    Handels RL; Wolfs CA; Aalten P; Joore MA; Verhey FR; Severens JL
    Alzheimers Dement; 2014 Mar; 10(2):225-37. PubMed ID: 23727080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical review of economic evaluations in multiple myeloma: an overview of the economic evidence and quality of the methodology.
    Gaultney JG; Redekop WK; Sonneveld P; Uyl-de Groot CA
    Eur J Cancer; 2011 Jul; 47(10):1458-67. PubMed ID: 21561761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist.
    Doble B; Tan M; Harris A; Lorgelly P
    Expert Rev Mol Diagn; 2015 Feb; 15(2):235-54. PubMed ID: 25142227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost collection and analysis for health economic evaluation.
    Smith KA; Rudmik L
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):192-9. PubMed ID: 23641023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of economic evaluations of treatments for patients with epilepsy.
    Wijnen BFM; van Mastrigt GAPG; Evers SMAA; Gershuni O; Lambrechts DAJE; Majoie MHJM; Postulart D; Aldenkamp BAP; de Kinderen RJA
    Epilepsia; 2017 May; 58(5):706-726. PubMed ID: 28098939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation.
    Nicholson A; Mahon J; Boland A; Beale S; Dwan K; Fleeman N; Hockenhull J; Dundar Y
    Health Technol Assess; 2015 Oct; 19(87):i-xxxi, 1-191. PubMed ID: 26507078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is complementary and alternative medicine (CAM) cost-effective? A systematic review.
    Herman PM; Craig BM; Caspi O
    BMC Complement Altern Med; 2005 Jun; 5():11. PubMed ID: 15932647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic Evaluations of Thrombophilia Screening Prior to Prescribing Combined Oral Contraceptives: A Systematic and Critical Review.
    Vernon E; Hiedemann B; Bowie BH
    Appl Health Econ Health Policy; 2017 Oct; 15(5):583-595. PubMed ID: 28290105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time.
    Sandmann FG; Franken MG; Steenhoek A; Koopmanschap MA
    Health Policy; 2013 Oct; 112(3):285-96. PubMed ID: 23628483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is a rapid review? A methodological exploration of rapid reviews in Health Technology Assessments.
    Harker J; Kleijnen J
    Int J Evid Based Healthc; 2012 Dec; 10(4):397-410. PubMed ID: 23173665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer.
    Diaby V; Tawk R; Sanogo V; Xiao H; Montero AJ
    Breast Cancer Res Treat; 2015 May; 151(1):27-40. PubMed ID: 25893588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferability of economic evaluations of medical technologies: a new technology for orthopedic surgery.
    Steuten L; Vallejo-Torres L; Young T; Buxton M
    Expert Rev Med Devices; 2008 May; 5(3):329-36. PubMed ID: 18452383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations.
    Eaton J; Mealing S; Thompson J; Moat N; Kappetein P; Piazza N; Busca R; Osnabrugge R
    J Med Econ; 2014 May; 17(5):365-75. PubMed ID: 24611813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review.
    Frederix GW; Severens JL; Hövels AM
    Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):675-85. PubMed ID: 26176753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making economic evaluations more helpful for treatment choices in haemophilia.
    Drummond M; Houwing N; Slothuus U; Giangrande P
    Haemophilia; 2017 Mar; 23(2):e58-e66. PubMed ID: 28111847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(17):1-69. PubMed ID: 27516814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
    Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
    Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.